Enforcement record

Business Suspension Order disclosure naming 株式会社関西メディコ

株式会社関西メディコ (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)

This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.

Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareGovernment disclosure16 March 2017

Action type

Business Suspension Order

Law

Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices

Authority

Ministry of Health, Labour and Welfare

Action date

16 March 2017

Current page: Enforcement record

This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.

Source verification

Public-source and preservation status

Publishing authority: Ministry of Health, Labour and Welfare
Official source URL: Recorded by RegBase
Entity match: Not confirmed; shown under the published name
Kiroku preservation: Completed archive verified; Captured: Jul 12, 2026, 03:31 PM JST

“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.

Open the official source links in the section below to review the original disclosure.

Action summary

Company: 株式会社関西メディコJapanese only
Original: 株式会社関西メディコ
Governing law: Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
医薬品医療機器等法
Action type: Business Suspension Order
業務停止命令
Action date: 16 March 2017
Issuing authority: Ministry of Health, Labour and Welfare
厚生労働省
Industry context: 医薬品販売

Violation

Machine-translated summary — verify against original

Regarding the violation of the Act on Securing Quality, Efficacy, and Safety of Pharmaceuticals and Medical Devices, a counterfeit of the hepatitis C treatment drug Harvoni Combination Tablets was discovered.

Show original Japanese text

医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律に違反し、C型肝炎治療薬「ハーボニー配合錠」の偽造品が発見された件について。

Compliance context

High

A formal order requiring suspension of business activities for the covered scope or period.

Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices.

Escalate for legal or third-party risk review before onboarding or continuing a material relationship.

This context is an operational aid for review workflows, not a credit opinion or legal conclusion.

Open original sources and verification detailsOfficial URL, direct PDF, and Kiroku archive

Original Ministry of Health, Labour and Welfare source (Japanese)Open preserved source and evidence pack

Extracted at: 2026-04-24T23:35:31.814+00:00
Evidence checked: 2026-04-24T23:35:31.814+00:00
Archive captured: 2026-07-12T06:31:56.179704+00:00

Show audit JSON

{
  "record": {
    "id": "44b1861d-ac95-4acd-967f-f096d4375eba",
    "url": "https://regbase.jp/en/enforcement/other-guan-xi-medeiko-20170316",
    "company_name_original": "株式会社関西メディコ",
    "company_name_registry": null,
    "corporate_number": null,
    "law": {
      "ja": "医薬品医療機器等法",
      "en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
    },
    "action_type": {
      "ja": "業務停止命令",
      "en": "Business Suspension Order"
    },
    "authority": {
      "ja": "厚生労働省",
      "en": "Ministry of Health, Labour and Welfare"
    }
  },
  "entity_match": {
    "status": "unresolved",
    "confidence": 85,
    "method": "nta_strict_name_nationally_unique",
    "method_label": "nta_strict_name_nationally_unique",
    "notes": "NTA full-download lookup found a nationally unique exact registered-name candidate (株式会社関西メディコ). No Corporate Number was present in the disclosure, so this remains a likely match."
  },
  "review": {
    "status": "unreviewed",
    "label": "Machine extracted"
  },
  "compliance_context": {
    "severity": "High",
    "actionMeaning": "A formal order requiring suspension of business activities for the covered scope or period.",
    "practicalNote": "Escalate for legal or third-party risk review before onboarding or continuing a material relationship.",
    "lawContext": "Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices."
  },
  "evidence": {
    "recordUrl": "https://regbase.jp/en/enforcement/other-guan-xi-medeiko-20170316",
    "officialSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000155435.html",
    "officialDocumentUrl": null,
    "archiveUrl": "https://kiroku.today/a/8a30242241hf0g05",
    "archivedSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000155435.html",
    "archiveCapturedAt": "2026-07-12T06:31:56.179704+00:00",
    "extractedAt": "2026-04-24T23:35:31.814+00:00",
    "translatedAt": "2026-05-01T06:50:42.123+00:00",
    "evidenceCheckedAt": "2026-04-24T23:35:31.814+00:00",
    "generatedAt": "2026-09-18T19:21:51.979Z"
  },
  "limitations": [
    "RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
    "English summaries are provided for reference. The original Japanese source is authoritative.",
    "Possible or unresolved entity matches should be manually verified before use in a decision."
  ]
}

The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.

Language

日本語版を見る (Japanese)

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.